Liver Cancer Statistics
An estimated 21,370 men and women (15,190 and 6,180 women) will be diagnosed and 18,410 men and women will die from primary liver cancer in 2008 according to the National Cancer Institute.
The following statistics are based on research from the National Cancer Institute:
- Primary liver cancer — The overall 5-year survival rate from 1996-2004 for primary liver cancer was 11.7%.
- Colon and/or rectal (colorectal) cancer with liver metastasis — The relative 5-year survival rate is 10.8%.
- Stomach cancer with liver metastasis — The relative 5-year survival rate is 3.7%.
- Pancreas with liver metastasis — The relative 5-year survival rate is 1.8%.
- Esophagus cancer with liver metastasis — The relative 5-year survival rate is 2.8%.
- Breast cancer with liver metastasis — The relative 5-year survival rate is 27.1%.
- Lung cancer with liver metastasis — The relative 5-year survival rate is 2.8%.
- Skin cancer with liver metastasis — The relative 5-year survival rate is 16.6%.
Dr. Arnold Smith and his dedicated team at the North Central Mississippi Regional Cancer Center employ immunotherapy, an innovative treatment that works to restore the immune system that age and cancer break down, helping the body fight back. Combined with radiation therapy to debulk cancer, molecular targeted therapies to arrest host defenses, genomic assays, and chemotherapy when necessary, immunotherapy helps patients live a higher-quality, longer life.
